NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS)

114 filings reported holding NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share as of Q3 2024.
NewAmsterdam Pharma Co N.V. - Ordinary Shares, Nominal value 0.12 per share (NAMS) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 77.1M shares of 112M outstanding shares and own 68.68% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (12.9M shares), FCPM III SERVICES B.V. (11.8M shares), Bain Capital Life Sciences Investors, LLC (10.5M shares), RA CAPITAL MANAGEMENT, L.P. (8.06M shares), VIKING GLOBAL INVESTORS LP (8.02M shares), Medicxi Ventures Management (Jersey) Ltd (2.87M shares), Cormorant Asset Management, LP (2.47M shares), JANUS HENDERSON GROUP PLC (1.54M shares), BVF INC/IL (1.52M shares), and Polar Capital Holdings Plc (1.51M shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.